0,963  0,003  Atherosclerosis treatment
0,889  0,001  HDL-cholesterol increasing
0,827  0,004  Hypolipemic
0,818  0,004  Myocardial infarction treatment
0,765  0,005  Lipoprotein disorders treatment
0,729  0,009  Analgesic, non-opioid
0,689  0,005  Vascular (periferal) disease treatment
0,686  0,004  Allergic rhinitis treatment
0,678  0,006  Antiischemic
0,659  0,003  Diabetic nephropathy treatment
0,672  0,017  Antidiabetic
0,672  0,017  Cyclophilin D inhibitor
0,651  0,004  Rhinitis treatment
0,658  0,018  Analgesic
0,617  0,005  Myocardial ischemia treatment
0,591  0,015  Antiallergic
0,579  0,005  Antihypertriglyceridemic
0,569  0,005  Muscle relaxant
0,573  0,017  5 Hydroxytryptamine release stimulant
0,562  0,010  Hypoglycemic
0,542  0,029  Antiobesity
0,499  0,012  Antidiabetic symptomatic
0,486  0,013  Angiogenesis stimulant
0,460  0,015  Psychostimulant
0,472  0,037  Cognition disorders treatment
0,447  0,019  Chronic obstructive pulmonary disease treatment
0,511  0,083  Antiinflammatory
0,448  0,036  Antidepressant
0,402  0,005  CNS active muscle relaxant
0,406  0,009  Skeletal muscle relaxant
0,430  0,037  FMO1 substrate
0,430  0,044  Mood disorders treatment
0,437  0,061  Antibacterial
0,385  0,010  Pneumotoxic
0,398  0,036  Vasodilator, coronary
0,403  0,059  Antiasthmatic
0,353  0,025  5 Hydroxytryptamine uptake stimulant
0,345  0,018  Antimigraine
0,374  0,048  Antipsychotic
0,369  0,047  Spasmolytic
0,364  0,075  Toll-Like receptor 7 agonist
0,358  0,078  Toll-Like receptor agonist
0,310  0,041  GST M1-1 substrate
0,347  0,087  GABA C receptor rho-3 antagonist
0,273  0,022  Antiparkinsonian, tremor relieving
0,303  0,062  Antidiabetic (type 2)
0,295  0,058  Antipyretic
0,239  0,013  Antismoking
0,252  0,031  Acaricide
0,234  0,022  Carcinogenic, group 1
0,323  0,112  Histamine release inhibitor
0,227  0,019  Antitussive
0,247  0,039  Anticoagulant
0,239  0,037  Antianorexic
0,263  0,074  Flavin-containing monooxygenase substrate
0,252  0,066  Tyrosine 3 hydroxylase inhibitor
0,243  0,060  Antihypotensive
0,294  0,114  GST A substrate
0,218  0,039  5 Hydroxytryptamine 3E antagonist
0,252  0,076  Teratogen
0,235  0,063  Antiparkinsonian, rigidity relieving
0,183  0,019  Antineoplastic alkaloid
0,262  0,098  Analeptic
0,248  0,088  Radiosensitizer
0,198  0,040  UGT2B9 substrate
0,258  0,102  CTGF expression inhibitor
0,252  0,100  FMO3 substrate
0,250  0,098  CYP1A2 substrate
0,194  0,046  Phospholipase A2 inhibitor
0,228  0,080  Embryotoxic
0,157  0,014  5 Hydroxytryptamine 1 agonist
0,217  0,079  Peptidyltransferase inhibitor
0,189  0,052  Toxic, respiratory center
0,156  0,020  Carcinogenic, group 2A
0,160  0,024  Ca2+-transporting ATPase inhibitor
0,251  0,120  Antihypertensive
0,212  0,084  RNA-directed DNA polymerase inhibitor
0,196  0,070  Sleep disorders treatment
0,125  0,003  Cholesterol ester transfer protein antagonist
0,137  0,015  Glutamate (mGluR) agonist
0,222  0,103  UGT1A9 substrate
0,306  0,187  Caspase 9 stimulant
0,154  0,035  Microtubule formation inhibitor
0,259  0,141  Immunosuppressant
0,250  0,133  CYP3A4 substrate
0,122  0,006  Cathepsin L2 inhibitor
0,200  0,086  Antialcoholic
0,137  0,024  GST T1-1 substrate
0,214  0,103  DNA synthesis inhibitor
0,115  0,005  Glutamate (mGluR7) antagonist
0,134  0,025  Acetylcholine nicotinic antagonist
0,260  0,153  Antipruritic, allergic
0,207  0,100  Vasodilator
0,221  0,115  UGT2B4 substrate
0,120  0,014  Antiviral (Hepatitis A)
0,222  0,117  Respiratory analeptic
0,111  0,008  Antidote, organophosphates
0,146  0,043  Cystathionine beta-synthase inhibitor
0,175  0,075  Antirickettsial
0,188  0,089  Neurotrophic factor enhancer
0,248  0,152  CYP2C9 substrate
0,122  0,026  Antibiotic
0,167  0,072  UGT2B10 substrate
0,190  0,101  VCAM1 expression inhibitor
0,153  0,066  Genotoxic
0,097  0,010  Potassium channel intermediate-conductance Ca-activated blocker
0,140  0,054  Cathepsin H inhibitor
0,132  0,046  Excitatory amino acid transporter EAAC1 inhibitor
0,109  0,024  Nicotinic alpha4beta2 receptor antagonist
0,122  0,037  Prolactin inhibitor
0,188  0,104  ErbB-1 antagonist
0,160  0,079  Prostatic (benign) hyperplasia treatment
0,129  0,052  Antiprotozoal (Babesia)
0,157  0,080  Prostate disorders treatment
0,118  0,042  Creatine kinase inhibitor
0,160  0,084  Aldehyde oxidase substrate
0,089  0,014  Nicotinic receptor alpha7 subunit antagonist
0,224  0,151  Interleukin 2 agonist
0,136  0,064  Alpha-N-acetylglucosaminidase inhibitor
0,187  0,114  Cytostatic
0,135  0,063  Antihemorrhagic
0,154  0,083  Antiviral (Hepatitis C)
0,094  0,024  Acetylcholine M5 receptor agonist
0,109  0,040  Acetylcholine M3 receptor agonist
0,207  0,138  Antihypoxic
0,078  0,009  Glutamate (mGluR group II) agonist
0,174  0,106  VEGF expression inhibitor
0,163  0,097  Antiviral (Hepatitis)
0,074  0,009  Glutamate (mGluR2) agonist
0,140  0,076  SULT1A3 substrate
0,184  0,121  Cardiovascular analeptic
0,218  0,156  Vasodilator, peripheral
0,084  0,025  Adrenaline uptake inhibitor
0,098  0,040  Factor XII inhibitor
0,125  0,068  Gastritis treatment
0,137  0,079  UGT2B15 substrate
0,182  0,124  Nitric-oxide synthase stimulant
0,147  0,090  Antihelmintic (Nematodes)
0,144  0,088  UGT1A3 substrate
0,125  0,069  Cholinergic antagonist
0,167  0,113  Antiparasitic
0,086  0,032  Neuronal nicotinic receptor antagonist
0,122  0,069  Acetylcholine antagonist
0,088  0,036  Narcotic antagonist
0,154  0,101  Sedative
0,155  0,103  Antihelmintic
0,173  0,122  UGT1A6 substrate
0,069  0,019  Acetylcholine M1 receptor agonist
0,098  0,048  Restless leg syndrome treatment
0,221  0,172  Ulceration
0,087  0,038  5 Hydroxytryptamine agonist
0,067  0,020  Alpha-mannosidase inhibitor
0,055  0,008  Cathepsin F inhibitor
0,157  0,111  UGT1A1 substrate
0,073  0,029  Dopamine uptake inhibitor
0,061  0,017  Glutamate (mGluR5) agonist
0,070  0,027  Acetylcholine muscarinic agonist
0,124  0,081  Cocaine dependence treatment
0,063  0,020  Glutamate (mGluR group I) agonist
0,148  0,106  Cytotoxic
0,129  0,087  Cell wall synthesis inhibitor
0,161  0,119  Insulin sensitizer
0,063  0,022  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,088  0,047  Glutamate receptor agonist
0,128  0,087  Antimutagenic
0,105  0,064  Carcinogenic, group 2B
0,156  0,116  Abortion inducer
0,116  0,078  Contraceptive female
0,091  0,054  Androgen antagonist
0,062  0,024  Dopamine transporter inhibitor
0,058  0,021  Mineralocorticoid receptor antagonist
0,136  0,098  UGT2B7 substrate
0,103  0,067  Ferrochelatase inhibitor
0,040  0,004  CC chemokine 8 receptor antagonist
0,106  0,070  Mucolytic
0,256  0,220  5 Hydroxytryptamine release inhibitor
0,278  0,244  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,089  0,056  Acetylcholine agonist
0,192  0,161  Gastrin inhibitor
0,141  0,110  Sensitization
0,059  0,030  mTOR inhibitor
0,118  0,092  Antifungal enhancer
0,068  0,043  Glutamate (mGluR6) antagonist
0,121  0,095  Nav1.6 sodium channel blocker
0,045  0,020  Progesterone antagonist
0,050  0,025  Mannosidase inhibitor
0,103  0,080  Anesthetic local
0,107  0,085  Shock treatment
0,193  0,171  Cholesterol antagonist
0,062  0,042  Antimycoplasmal
0,051  0,031  HCV NS3/NS4A protease inhibitor
0,055  0,035  Protein 50S ribosomal subunit inhibitor
0,132  0,112  Uterine stimulant
0,122  0,105  Acetylcholine M1 receptor antagonist
0,211  0,195  TNF expression inhibitor
0,040  0,025  Vascular adhesion protein 1 inhibitor
0,028  0,013  Acid ceramidase inhibitor
0,066  0,052  MDM2 inhibitor
0,151  0,139  Aldehyde oxidase inhibitor
0,153  0,142  NOS2 expression inhibitor
0,082  0,071  Antidote, mercury
0,077  0,066  Antispirochetal
0,082  0,072  Bromodomain-containing protein 2 inhibitor
0,066  0,057  SULT2A1 substrate
0,050  0,043  Nicotinic alpha3beta2 receptor antagonist
0,086  0,080  Antiemetic
0,040  0,034  Guanylate cyclase inhibitor
0,065  0,060  Cathepsin G inhibitor
0,078  0,073  mTOR complex 2 inhibitor
0,028  0,024  Acetylcholine M4 receptor agonist
0,087  0,083  UGT2B11 substrate
0,028  0,025  Dipeptidyl peptidase I inhibitor
0,084  0,082  UDP-glucose 4-epimerase inhibitor
0,037  0,036  Antiprotozoal (Histomonas)

